Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCD | O00767 | 9/20 | 0.57 |
| ▸ | TP53 | P04637 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | CACNA1G | O43497 | 1/20 | 0.41 |
| ▸ | CACNA1H | O95180 | 1/20 | 0.41 |
| ▸ | CACNA1I | Q9P0X4 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14047625 | 1.00 | SCD (0.57) | SCDTP53ALDH1A1TSHRRAB9A | |
| SCHEMBL14047539 | 0.94 | SCD (0.53) | SCDALDH1A1HPGDHDAC1KMT2A | |
| SCHEMBL14047595 | 0.90 | SCD (0.56) | SCDALDH1A1HPGDHDAC1CACNA1G | |
| SCHEMBL14047421 | 0.90 | SCD (0.59) | SCDTP53ALDH1A1TSHRRAB9A | |
| SCHEMBL14047409 | 0.87 | SCD (0.47) | SCDTP53TSHRRAB9AHDAC1 | |
| SCHEMBL14047603 | 0.86 | SCD (0.57) | SCDALDH1A1TSHRMEN1KMT2A | |
| SCHEMBL14047404 | 0.85 | SCD (0.47) | SCDTP53TSHRRAB9AHDAC1 | |
| SCHEMBL14047406 | 0.84 | SCD (0.44) | SCDTP53ALDH1A1TSHRMEN1 | |
| SCHEMBL14047581 | 0.83 | ALDH1A1 (0.45) | SCDALDH1A1RAB9AHPGDMEN1 | |
| SCHEMBL14047531 | 0.83 | SCD (0.41) | SCDALDH1A1HPGDKMT2ACACNA1G |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008127349-A2 | HETEROCYCLIC COMPOUNDS SUITABLE FOR THE TREATMENT OF DISEASES RELATED TO ELEVATED LIPID LEVEL | NOVARTIS AG (CH) | 2008-10-23 | — | — | WO | disclosed |